{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:17:29Z","timestamp":1772165849092,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Concerns have grown that post-acute sequelae of COVID-19 may affect significant numbers of survivors. However, the analyses used to guide policy-making for Australia\u2019s national and state re-opening plans have not incorporated non-acute illness in their modelling. We, therefore, develop a model by which to estimate the potential acute and post-acute COVID-19 burden using disability-adjusted life years (DALYs) associated with the re-opening of Australian borders and the easing of other public health measures, with particular attention to longer-term, post-acute consequences and the potential impact of permanent functional impairment following COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A model was developed based on the European Burden of Disease Network protocol guideline and consensus model to estimate the burden of COVID-19 using DALYs. Data inputs were based on publicly available sources. COVID-19 infection and different scenarios were drawn from the Doherty Institute\u2019s modelling report to estimate the likely DALY losses under the Australian national re-opening plan. Long COVID prevalence, post-intensive care syndrome (PICS) and potential permanent functional impairment incidences were drawn from the literature. DALYs were calculated for the following health states: the symptomatic phase, Long COVID, PICS and potential permanent functional impairment (e.g., diabetes, Parkinson\u2019s disease, dementia, anxiety disorders, ischemic stroke). Uncertainty and sensitivity analysis were performed to examine the robustness of the results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mortality was responsible for 72-74% of the total base case COVID-19 burden. Long COVID and post-intensive care syndrome accounted for at least 19 and 3% of the total base case DALYs respectively. When included in the analysis, potential permanent impairment could contribute to 51-55% of total DALYs lost.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The impact of Long COVID and potential long-term post-COVID disabilities could contribute substantially to the COVID-19 burden in Australia\u2019s post-vaccination setting. As vaccination coverage increases, the share of COVID-19 burden driven by longer-term morbidity rises relative to mortality. As Australia re-opens, better estimates of the COVID-19 burden can assist with decision-making on pandemic control measures and planning for the healthcare needs of COVID-19 survivors. Our estimates highlight the importance of valuing the morbidity of post-COVID-19 sequelae, above and beyond simple mortality and case statistics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-022-13169-x","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:02:24Z","timestamp":1649930544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan"],"prefix":"10.1186","volume":"22","author":[{"given":"Mary Rose","family":"Angeles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sithara","family":"Wanni Arachchige Dona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huong Dieu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long Khanh-Dao","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hensher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"13169_CR1","volume-title":"Race to 80: our best shot at living with COVID: Grattan Institute","author":"S Duckett","year":"2021","unstructured":"Duckett S, Wood D, Coates B, Mackey W, Crowley T, Stobart A. Race to 80: our best shot at living with COVID: Grattan Institute; 2021; Cited 2021 October 01. Available from: https:\/\/grattan.edu.au\/wp-content\/uploads\/2021\/07\/Race-to-80-our-best-shot-at-living-with-COVID-Grattan-Report.pdf."},{"issue":"6","key":"13169_CR2","doi-asserted-by":"publisher","first-page":"e0252400","DOI":"10.1371\/journal.pone.0252400","volume":"16","author":"T Kompas","year":"2021","unstructured":"Kompas T, Grafton RQ, Che TN, Chu L, Camac J. Health and economic costs of early and delayed suppression and the unmitigated spread of COVID-19: the case of Australia. PLoS One. 2021;16(6):e0252400.","journal-title":"PLoS One"},{"key":"13169_CR3","volume-title":"Australia\u2019s COVID-19 response: the story so far: Grattan Institute","author":"S Duckett","year":"2020","unstructured":"Duckett S, Stobart A. Australia\u2019s COVID-19 response: the story so far: Grattan Institute; 2020; Cited 2021 November 08. Available from: https:\/\/grattan.edu.au\/news\/australias-covid-19-response-the-story-so-far\/."},{"key":"13169_CR4","volume-title":"Government response to the COVID-19 outbreak: Department of Health","author":"Department of Health","year":"2021","unstructured":"Department of Health. Government response to the COVID-19 outbreak: Department of Health; 2021; Cited 2021 November 08. Available from: https:\/\/www.health.gov.au\/news\/health-alerts\/novel-coronavirus-2019-ncov-health-alert\/government-response-to-the-covid-19-outbreak."},{"key":"13169_CR5","volume-title":"National Plan to transition Australia\u2019s National COVID-19 Response (July 2021) Australia","author":"Department of the Prime Minister and Cabinet","year":"2021","unstructured":"Department of the Prime Minister and Cabinet. National Plan to transition Australia\u2019s National COVID-19 Response (July 2021) Australia 2021; Cited 2021 October 01. Available from: https:\/\/www.pmc.gov.au\/national-plan-transition-australias-national-covid-response."},{"key":"13169_CR6","volume-title":"Doherty modelling interim report to National Cabinet 17th September 2021 Australia: Doherty Institute","author":"Doherty Institute","year":"2021","unstructured":"Doherty Institute. Doherty modelling interim report to National Cabinet 17th September 2021 Australia: Doherty Institute; 2021; Cited 2021 September 20. Available from: https:\/\/www.doherty.edu.au\/uploads\/content_doc\/DOHERTY_MODELLING_INTERIM_REPORT_TO_NATIONAL_CABINET_17TH_SEPTEMBER_2021.pdf."},{"key":"13169_CR7","unstructured":"Hensher M, Angeles MR, de Graaf B, Campbell J, Athan E, Haddock R. Deeble Institute issues brief no 40. Managing the long term health consequences of COVID-19 in Australia Canberra, Australia: Australian Healthcare and Hospitals Association; 2021; Cited 2021 August 01. Available from: https:\/\/ahha.asn.au\/news\/long-term-health-consequences-covid-19-can-value-based-health-care-provide-way-forward."},{"key":"13169_CR8","doi-asserted-by":"publisher","first-page":"n693","DOI":"10.1136\/bmj.n693","volume":"372","author":"D Ayoubkhani","year":"2021","unstructured":"Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.","journal-title":"BMJ."},{"issue":"5","key":"13169_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416\u201327.","journal-title":"Lancet Psychiatry"},{"key":"13169_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/ijph.2021.619011","volume":"66","author":"G Wyper","year":"2021","unstructured":"Wyper G, Assun\u00e7\u00e3o R, Colzani E, Grant I, Haagsma JA, Lagerweij G, et al. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. Int J Public Health. 2021;66:4.","journal-title":"Int J Public Health"},{"key":"13169_CR11","volume-title":"Burden of disease of COVID-19: Protocol for country studies","author":"European Burden of Disease Network","year":"2020","unstructured":"European Burden of Disease Network. Burden of disease of COVID-19: Protocol for country studies 2020; Cited 2021 August 01 Available from: https:\/\/www.burden-eu.net\/docs\/covid19-bod-protocol.pdf."},{"issue":"2","key":"13169_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/CCM.0b013e318232da75","volume":"40","author":"DM Needham","year":"2012","unstructured":"Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders\u2019 conference. Crit Care Med. 2012;40(2):502\u20139.","journal-title":"Crit Care Med"},{"key":"13169_CR13","volume-title":"Table 1.9 Life Tables, Australia, 2017-2019","author":"Australian Bureau of Statistics","year":"2020","unstructured":"Australian Bureau of Statistics. Table 1.9 Life Tables, Australia, 2017-2019. Canberra: ABS; 2020. Cited 2021 June 23 Available from: https:\/\/www.abs.gov.au\/statistics\/people\/population\/life-tables\/latest-release#data-download"},{"key":"13169_CR14","unstructured":"World Health Organization. The Global Burden of Disease concept The Global Burden of Disease concept; Cited 2021 August 01. 27-40]. Available from: https:\/\/www.who.int\/quantifying_ehimpacts\/publications\/en\/9241546204chap3.pdf."},{"key":"13169_CR15","volume-title":"Global Burden of Disease Study 2019 (GBD 2019) Results Seattle, United States: Institute for Health Metrics and Evaluation (IHME)","author":"Global Burden of Disease Collaborative Network","year":"2020","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020; Cited 2021 August 01 Available from: http:\/\/ghdx.healthdata.org\/gbd-results-tool."},{"key":"13169_CR16","volume-title":"Coronavirus (COVID-19) case numbers and statistics Australia","author":"Department of Health","year":"2021","unstructured":"Department of Health. Coronavirus (COVID-19) case numbers and statistics Australia 2021; Cited 2021 October 04. Available from: https:\/\/www.health.gov.au\/news\/health-alerts\/novel-coronavirus-2019-ncov-health-alert\/coronavirus-covid-19-case-numbers-and-statistics#covid19-summary-statistics."},{"issue":"1","key":"13169_CR17","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1186\/s12889-021-11893-4","volume":"21","author":"S Cuschieri","year":"2021","unstructured":"Cuschieri S, Calleja N, Devleesschauwer B, Wyper GMA. Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year. BMC Public Health. 2021;21(1):1827.","journal-title":"BMC Public Health"},{"key":"13169_CR18","unstructured":"Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021: Estimates of the prevalence of self-reported \u201clong COVID\u201d, and the duration of ongoing symptoms following confirmed coronavirus infection, using UK Coronavirus (COVID-19) Infection Survey data to 6 March 2021. UK: ONS; 2021; Cited 2021 September 01. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk\/1april2021."},{"key":"13169_CR19","doi-asserted-by":"publisher","first-page":"100193","DOI":"10.1016\/j.lanwpc.2021.100193","volume":"12","author":"B Liu","year":"2021","unstructured":"Liu B, Jayasundara D, Pye V, Dobbins T, Dore GJ, Matthews G, et al. Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia. Lancet Region Health-Western Pacific. 2021;12:100193.","journal-title":"Lancet Region Health-Western Pacific"},{"issue":"1","key":"13169_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-021-00910-9","volume":"11","author":"A-F Rousseau","year":"2021","unstructured":"Rousseau A-F, Minguet P, Colson C, Kellens I, Chaabane S, Delanaye P, et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann Intensive Care. 2021;11(1):1\u20139.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"13169_CR21","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/cc8848","volume":"14","author":"BH Cuthbertson","year":"2010","unstructured":"Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care. 2010;14(1):R6\u2013R.","journal-title":"Crit Care"},{"issue":"1","key":"13169_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-94637-z","volume":"11","author":"JG Hofhuis","year":"2021","unstructured":"Hofhuis JG, Schrijvers AJ, Schermer T, Spronk PE. Health-related quality of life in ICU survivors\u201410 years later. Sci Rep. 2021;11(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"9","key":"13169_CR23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/13696998.2019.1631831","volume":"22","author":"J Byrnes","year":"2019","unstructured":"Byrnes J, Ball J, Gao L, Kai Chan Y, Kularatna S, Stewart S, et al. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial. J Med Econ. 2019;22(9):945\u201352.","journal-title":"J Med Econ"},{"key":"13169_CR24","volume-title":"Global Burden of Disease Study 2019 (GBD 2019) Disability Weights Seattle, United States: Institute for Health Metrics and Evaluation (IHME)","author":"Global Burden of Disease Collaborative Network","year":"2020","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Disability Weights Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020; Cited 2021 August 01 Available from: http:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2019-disability-weights."},{"key":"13169_CR25","volume-title":"Modelling definitions and frequently asked questions","author":"Doherty Institute","year":"2021","unstructured":"Doherty Institute. Modelling definitions and frequently asked questions 2021; Cited 2021 October 01. Available from: https:\/\/www.doherty.edu.au\/news-events\/news\/modelling-definitions-and-frequently-asked-questions."},{"issue":"4","key":"13169_CR26","first-page":"223","volume":"5","author":"O Byambasuren","year":"2020","unstructured":"Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. Official J Assoc Med Microbiol Infect Dis Canada. 2020;5(4):223\u201334.","journal-title":"Official J Assoc Med Microbiol Infect Dis Canada"},{"issue":"12","key":"13169_CR27","doi-asserted-by":"publisher","first-page":"e0260843","DOI":"10.1371\/journal.pone.0260843","volume":"16","author":"C Martin","year":"2021","unstructured":"Martin C, Luteijn M, Letton W, Robertson J, McDonald S. A model framework for projecting the prevalence and impact of long-COVID in the UK. PLoS One. 2021;16(12):e0260843.","journal-title":"PLoS One"},{"key":"13169_CR28","doi-asserted-by":"crossref","unstructured":"Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43-55.","DOI":"10.1016\/S1473-3099(21)00460-6"},{"issue":"19","key":"13169_CR29","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF. What\u2019s the relative risk?A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690\u20131.","journal-title":"JAMA."},{"issue":"9","key":"13169_CR30","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jamacardio.2021.2065","volume":"6","author":"CJ Daniels","year":"2021","unstructured":"Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078\u201387.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"13169_CR31","doi-asserted-by":"publisher","first-page":"e048391","DOI":"10.1136\/bmjopen-2020-048391","volume":"11","author":"A Dennis","year":"2021","unstructured":"Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391.","journal-title":"BMJ Open"},{"issue":"5","key":"13169_CR32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s15010-021-01638-1","volume":"49","author":"A Fortini","year":"2021","unstructured":"Fortini A, Torrigiani A, Sbaragli S, Lo Forte A, Crociani A, Cecchini P, et al. COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge. Infection. 2021;49(5):1007\u201315.","journal-title":"Infection."},{"key":"13169_CR33","volume-title":"A detailed study of patients with long-haul COVID","author":"F Health","year":"2021","unstructured":"Health F. A detailed study of patients with long-haul COVID; 2021."},{"issue":"1","key":"13169_CR34","doi-asserted-by":"publisher","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","volume":"11","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.","journal-title":"Sci Rep"},{"issue":"13","key":"13169_CR35","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/jcm10132945","volume":"10","author":"MM Maestre-Mu\u00f1iz","year":"2021","unstructured":"Maestre-Mu\u00f1iz MM, Arias \u00c1, Mata-V\u00e1zquez E, Mart\u00edn-Toledano M, L\u00f3pez-Larramona G, Ruiz-Chicote AM, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10(13):2945.","journal-title":"J Clin Med"},{"issue":"1","key":"13169_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.dsx.2020.12.024","volume":"15","author":"T Sathish","year":"2021","unstructured":"Sathish T, Cao Y. Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients? Diabetes Metab Syndr. 2021;15(1):147\u20138.","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"13169_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmet.2021.01.016","volume":"33","author":"DJ Drucker","year":"2021","unstructured":"Drucker DJ. Diabetes, obesity, metabolism and SARS-CoV-2 infection: the end of the beginning. Cell Metab. 2021;33(3):479\u201398.","journal-title":"Cell Metab"},{"issue":"1","key":"13169_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","volume":"17","author":"S Lim","year":"2021","unstructured":"Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11\u201330.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"13169_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00134-020-06313-x","volume":"47","author":"C McCue","year":"2021","unstructured":"McCue C, Cowan R, Quasim T, Puxty K, McPeake J. Long term outcomes of critically ill COVID-19 pneumonia patients: early learning. Intensive Care Med. 2021;47(2):240\u20131.","journal-title":"Intensive Care Med"},{"key":"13169_CR40","volume-title":"Ersatz Version 1.35 Brisbane, Australia: EpiGear International","author":"EpiGear International","year":"2017","unstructured":"EpiGear International. Ersatz Version 1.35 Brisbane, Australia: EpiGear International; 2017; Cited 2021 August 01. Available from: https:\/\/www.epigear.com\/index_files\/ersatz.html."},{"key":"13169_CR41","volume-title":"The first year of COVID-19 in Australia: direct and indirect health effects: Australian Institute of Health and Welfare","author":"Australian Institute of Health and Welfare","year":"2021","unstructured":"Australian Institute of Health and Welfare. The first year of COVID-19 in Australia: direct and indirect health effects: Australian Institute of Health and Welfare; 2021; Cited 2021 October 01. Available from: https:\/\/www.aihw.gov.au\/reports\/burden-of-disease\/the-first-year-of-covid-19-in-australia\/summary."},{"issue":"8","key":"13169_CR42","doi-asserted-by":"publisher","first-page":"e049619","DOI":"10.1136\/bmjopen-2021-049619","volume":"11","author":"D John","year":"2021","unstructured":"John D, Narassima MS, Menon J, Rajesh JG, Banerjee A. Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis. BMJ Open. 2021;11(8):e049619.","journal-title":"BMJ Open"},{"issue":"21","key":"13169_CR43","doi-asserted-by":"publisher","first-page":"e199-e","DOI":"10.3346\/jkms.2020.35.e199","volume":"35","author":"MW Jo","year":"2020","unstructured":"Jo MW, Go DS, Kim R, Lee SW, Ock M, Kim YE, et al. The burden of disease due to COVID-19 in Korea using disability-adjusted life years. J Korean Med Sci. 2020;35(21):e199-e.","journal-title":"J Korean Med Sci"},{"issue":"12","key":"13169_CR44","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.3390\/ijerph17124233","volume":"17","author":"MC Nurchis","year":"2020","unstructured":"Nurchis MC, Pascucci D, Sapienza M, Villani L, D'Ambrosio F, Castrini F, et al. Impact of the burden of COVID-19 in Italy: results of disability-adjusted life years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17(12):4233.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"13169_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12939-021-01547-7","volume":"20","author":"GMA Wyper","year":"2021","unstructured":"Wyper GMA, Fletcher E, Grant I, Harding O, de Haro Moro MT, Stockton DL, et al. Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland. Int J Equity Health. 2021;20(1):214.","journal-title":"Int J Equity Health"},{"key":"13169_CR46","doi-asserted-by":"publisher","first-page":"686700","DOI":"10.3389\/fpubh.2021.686700","volume":"9","author":"G Salinas-Escudero","year":"2021","unstructured":"Salinas-Escudero G, Toledano-Toledano F, Garc\u00eda-Pe\u00f1a C, Parra-Rodr\u00edguez L, Granados-Garc\u00eda V, Carrillo-Vega MF. Disability-adjusted life years for the COVID-19 pandemic in the Mexican population. Front Public Health. 2021;9:686700.","journal-title":"Front Public Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13169-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T19:04:18Z","timestamp":1668279858000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13169-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13169"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13169-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1066181\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"757"}}